Business · 17/08/2010
FDA Announces Draft Revised Guidance on Residual Solvents in New Veterinary Medicinal Products
The FDA is seeking public comments on a revised guidance for the industry on acceptable residual solvents in new veterinary medicinal products, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), to ensure animal and human safety.
Original source language: Federal Register — Health and Human ServicesOpen original release →